A Comprehensive Guide to Fibrous Dysplasia and McCune-Albright Syndrome

High-Yield Summary

• Fibrous dysplasia (FD) is a benign fibro-osseous lesion caused by postzygotic activating mutations in the GNAS gene, leading to abnormal bone remodeling and structural weakness.
• McCune-Albright Syndrome (MAS) combines polyostotic FD with café-au-lait skin pigmentation and endocrine hyperfunction, requiring multidisciplinary management.
• Surgical intervention focuses on fracture prevention, deformity correction, and functional restoration, with careful timing to avoid premature fixation failure.
• Radiographic diagnosis hinges on characteristic ground-glass appearance and lesion distribution; biopsy is reserved for atypical cases or malignancy suspicion.
• Optimal outcomes depend on individualized surgical planning, balancing lesion biology, skeletal maturity, and endocrine control.

Clinical Fundamentals

Fibrous dysplasia arises from a somatic mutation in the GNAS gene encoding the stimulatory G-protein alpha subunit, causing constitutive activation of adenylate cyclase. This disrupts normal osteoblastic differentiation, replacing mature lamellar bone with immature woven bone and fibrous stroma. The resulting bone is structurally weak and prone to deformity and fracture.

Anatomically, FD can be monostotic (single bone) or polyostotic (multiple bones), with predilection for the craniofacial skeleton, femur, tibia, ribs, and pelvis. MAS represents a syndromic form with systemic manifestations including endocrine hyperfunction (precocious puberty, hyperthyroidism, growth hormone excess) and characteristic café-au-lait macules with irregular borders.

Biomechanically, FD lesions compromise bone strength through disorganized matrix and altered load distribution, increasing fracture risk and deformity progression, particularly in weight-bearing long bones. Skeletal maturity influences lesion activity; lesions tend to stabilize after puberty but may remain active in MAS.

Epidemiologically, FD is rare, with an estimated prevalence of 1:30,000. MAS is even less common but carries higher morbidity due to systemic involvement.

Classification & Diagnosis

Diagnostic Pearls:

• Ground-glass matrix on CT is pathognomonic; MRI assists in soft tissue and neurovascular assessment.
• Bone scintigraphy delineates extent in polyostotic disease.
• Biopsy is indicated if malignancy is suspected (rapid growth, pain, cortical destruction).
• Endocrine evaluation is mandatory in suspected MAS to optimize perioperative management.

Common Pitfalls:

• Misdiagnosing FD as malignancy due to aggressive radiographic features.
• Overlooking endocrine abnormalities leading to poor surgical outcomes.
• Underestimating lesion activity and skeletal maturity, resulting in premature fixation failure.

Decision-Making Algorithm

Surgical Approach Selection:

• Intramedullary fixation preferred for long bone deformities to provide load-sharing and accommodate lesion biology.
• Curettage and bone grafting have limited efficacy due to lesion recurrence; structural grafts or allografts may be considered in select cases.
• Osteotomies for deformity correction should be staged and planned with 3D imaging to avoid neurovascular injury.
• Craniofacial FD requires tailored approaches balancing cosmetic and functional outcomes.

Surgical Mastery & Pearls

Step 1: Preoperative Planning

• Obtain high-resolution CT with 3D reconstruction to define lesion extent and deformity.
• Coordinate with endocrinology to ensure hormonal control.
• Plan fixation strategy considering lesion size, location, and bone quality.

Step 2: Exposure and Lesion Assessment

• Use minimally invasive approaches when possible to preserve soft tissue envelope.
• Identify and protect neurovascular structures, especially in craniofacial and proximal femoral lesions.

Step 3: Lesion Management

• Avoid aggressive curettage; focus on mechanical stabilization.
• Intramedullary nails provide superior biomechanical support and reduce refracture risk.
• Use locking plates cautiously; risk of stress shielding and hardware failure is higher in FD bone.

Step 4: Deformity Correction

• Perform osteotomies at sites of maximal deformity; consider staged corrections in severe cases.
• Use intraoperative fluoroscopy or navigation to confirm alignment.

Step 5: Postoperative Care

• Early mobilization balanced with protection of fixation.
• Monitor for hardware failure or lesion progression with serial imaging.

Intraoperative Red Flags:

• Excessive bleeding due to hypervascularity; prepare for hemostatic control.
• Poor bone purchase leading to hardware loosening; consider augmenting fixation.
• Unexpected lesion extension beyond imaging; reassess surgical plan intraoperatively.

Technical Tips:

• Use reamers cautiously to avoid cortical breach.
• Consider adjunctive bisphosphonate therapy postoperatively to reduce lesion activity.
• Maintain a low threshold for multidisciplinary consultation in complex cases.

Evidence-Based Synthesis

Recent literature underscores the importance of individualized surgical timing in FD and MAS. Studies demonstrate that early fixation in active lesions correlates with higher rates of hardware failure and refracture, emphasizing the need for endocrine stabilization and skeletal maturity assessment before surgery.

Intramedullary fixation has emerged as the gold standard for long bone involvement, supported by biomechanical and clinical data showing superior load distribution and lower complication rates compared to plate fixation or curettage alone.

Bisphosphonates have shown promise in reducing bone pain and lesion activity but lack definitive evidence for altering surgical outcomes. Their role remains adjunctive, particularly in MAS patients with persistent endocrine activity.

Controversy persists regarding the extent of lesion resection; aggressive curettage has not demonstrated improved outcomes and may increase morbidity. Current consensus favors mechanical stabilization over lesion eradication.

Multidisciplinary management integrating endocrinology, radiology, and orthopaedic surgery is critical, as endocrine abnormalities directly impact bone healing and surgical success.

Master Class Pro-Tip

Mastery in managing fibrous dysplasia and McCune-Albright Syndrome hinges on anticipating the lesion’s biological behavior rather than solely its radiographic appearance. Prioritize endocrine optimization and skeletal maturity assessment to time surgery for maximal fixation durability. Employ intramedullary fixation as a biomechanically superior strategy, and resist the temptation for aggressive lesion curettage-stabilize the bone, respect its biology, and tailor deformity correction with precision. This approach transforms a challenging pathology into a manageable surgical entity, elevating outcomes from competent to exceptional.

Last Updated on June 2, 2026 by OrthoNet AI